AFP and hepatocellular carcinoma: The models appear to be unable to identify the risk of very early-stage cases due to their relatively low proportion in the study and the large overlap in the AFP and PIVKA-II levels between early-stage HCC and the risk groups (Additional file 2: Fig. S1a, b).